Lower IQ is associated with decreased clinical response to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder

Luigi Mazzone, Laura Reale, Valeria Mannino, Mariadonatella Cocuzza, Benedetto Vitiello

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Lower IQ is associated with decreased clinical response to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder'. Together they form a unique fingerprint.

Medicine & Life Sciences